Publisher Correction: The β20-β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions (Nature Communications (2017) DOI: 10.1038/s41467-017-01119-w);The β20-β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Herschhorn, Alon ^a,b   Gu, Christopher ^a   Moraca, Francesca ^c   Ma, Xiaochu ^d   Farrell, Mark ^e   Smith, Amos B ^e   Pancera, Marie ^f   Kwong, Peter D ^f   Schön, Arne ^g   Freire, Ernesto ^g   Abrams, Cameron ^c   Blanchard, Scott C ^h   Mothes, Walther ^d   Sodroski, Joseph G ^a,b,i  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Drexel University   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 120 BETA20; GLYCOPROTEIN GP 120 BETA21; UNCLASSIFIED DRUG; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN BINDING;

AMINO ACID; ANTIBODY; GENETIC ANALYSIS; MOLECULAR ANALYSIS; PROTEIN; VULNERABILITY;

ALLOSTERISM; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; IC50; MUTAGENESIS; NONHUMAN; PHENOTYPE; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS STRAIN; BETA SHEET; CHEMISTRY; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR PROBE; PHYSIOLOGY; PROTEIN CONFORMATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD4 ANTIGENS; HEK293 CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR PROBES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN CONFORMATION, BETA-STRAND;

EID: 85031943201     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-02463-7     Document Type: Erratum

References (50)

1. Allan, J. S. et al. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228, 1091-1094 (1985)
2. Wyatt, R., Sodroski, J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884-1888 (1998)
3. Choe, H. et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996)
4. Dalgleish, A. G. et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767 (1984)
5. Feng, Y., Broder, C. C., Kennedy, P. E., Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996)
6. Dragic, T. et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673 (1996)
7. Doranz, B. J. et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996)
8. Wu, L. et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183 (1996)
9. Trkola, A. et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187 (1996)
10. Furuta, R. A., Wild, C. T., Weng, Y., Weiss, C. D. Capture of an early fusionactive conformation of HIV-1 gp41. Nat. Struct. Biol. 5, 276-279 (1998)
11. He, Y. et al. Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites. J. Virol. 77, 1666-1671 (2003)
12. Koshiba, T., Chan, D. C. The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions. J. Biol. Chem. 278, 7573-7579 (2003)
13. Chan, D. C., Fass, D., Berger, J. M., Kim, P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273 (1997)
14. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., Wiley, D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430 (1997)
15. Lu, M., Blacklow, S. C., Kim, P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2, 1075-1082 (1995)
16. Tan, K., Liu, J., Wang, J., Shen, S., Lu, M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl Acad. Sci. USA 94, 12303-12308 (1997)
17. Melikyan, G. B. et al. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell. Biol. 151, 413-423 (2000)
18. Munro, J. B. et al. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science 346, 759-763 (2014)
19. Herschhorn,A. et al. Release of gp120 restraints leads to an entry-competent intermediate state of the HIV-1 envelope glycoproteins. MBio 7, e01598-16 (2016)
20. Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., Subramaniam, S. Molecular architecture of native HIV-1 gp120 trimers. Nature 455, 109-113 (2008)
21. Tran, E. E. et al. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog. 8, e1002797 (2012)
22. Wang, H. et al. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop. Proc. Natl Acad. Sci. USA 113, E7151-E7158 (2016)
23. Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659 (1998)
24. Herschhorn, A. et al. A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry. Nat. Chem. Biol. 10, 845-852 (2014)
25. Thali, M. et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67, 3978-3988 (1993)
26. Si, Z. et al. Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins. Proc. Natl Acad. Sci. USA 101, 5036-5041 (2004)
27. LaLonde, J. M. et al. Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors. J. Med. Chem. 55, 4382-4396 (2012)
28. Pancera, M. et al. Crystal structures of trimeric HIV envelope with small molecule-entry inhibitors BMS-378806 and BMS-626529. Nat. Chem. Biol. 13, 1115-1122 (2017)
29. Kwon, Y. D. et al. Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc. Natl Acad. Sci. USA 109, 5663-5668 (2012)
30. Pancera, M. et al. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 514, 455-461 (2014)
31. Guttman, M. et al. Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env. Nat. Commun. 6, 6144 (2015)
32. Walker, L. M. et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285-289 (2009)
33. Zhou, T. et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811-817 (2010)
34. Rizzuto, C. D. et al. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949-1953 (1998)
35. LaBranche, C. C. et al. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J. Virol. 73, 10310-10319 (1999)
36. Lee, J. H., Ozorowski, G., Ward, A. B. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer. Science 351, 1043-1048 (2016)
37. Pacheco, B. et al. Residues in the gp41 ectodomain regulate HIV-1 envelope glycoprotein conformational transitions induced by gp120-directed inhibitors. J. Virol. 91, e02219-16 (2016)
38. Madani, N. et al. Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155. J. Virol. 78, 3742-3752 (2004)
39. Yolamanova, M. et al. Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat. Nanotechnol. 8, 130-136 (2013)
40. Pan, R., Gorny, M. K., Zolla-Pazner, S., Kong, X. P. The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel. J. Virol. 89, 8003-8010 (2015)
41. Julien, J. P. et al. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342, 1477-1483 (2013)
42. Herschhorn, A. et al. An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors. PLoS ONE 6, e26731 (2011)
43. Herschhorn, A., Hizi, A. Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1. J. Med. Chem. 51, 5702-5713 (2008)
44. Doores, K. J. et al. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc. Natl Acad. Sci. USA 107, 13800-13805 (2010)
45. Miyazawa, S., Jernigan, R. L. Estimation of effective interresidue contact energies from protein crystal structures: quasi-chemical approximation. Macromolecules 18, 534-552 (1985)
46. Zhou, H., Zhou, Y. Quantifying the effect of burial of amino acid residues on protein stability. Proteins 54, 315-322 (2004)
47. Pettersen, E. F. et al. UCSF chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004)
48. Xiang, S. H. et al. Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 76, 9888-9899 (2002)
49. Finzi, A. et al. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. Mol. Cell 37, 656-667 (2010)
50. Kolchinsky, P., Kiprilov, E., Bartley, P., Rubinstein, R., Sodroski, J. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops. J. Virol. 75, 3435-3443 (2001)